EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Chylothorax After Thoracic Surgery: How We Manage It

Alberto Busetto iD, Giorgio Cannone, Luigi Lione, Alessandro Bonis, Vincenzo Verzeletti, Michele Battistel, Alessandro Rebusso, Samuele Nicotra, Andrea Dell'Amore, Federico Rea

Thoracic Cancer · 2025-03 · 16 (5)

DOI: 10.1111/1759-7714.70036 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Thoracic Cancer, online erschienen am 06.03.2025. Verfasst von Alberto Busetto und 9 weiteren Autor:innen. Beteiligte Einrichtung: Thoracic Surgery Unit, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, Padova, Italy. Hauptthemen laut MEDLINE: Chylothorax, Postoperative Complications, Thoracic Surgical Procedures. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chylothorax is a rare but insidious condition, characterized by the accumulation of chyle in the pleural space, which is particularly common after cardiothoracic surgeries. It presents significant challenges in both diagnosis and treatment. In this technical report, we present our experience in managing four cases of postsurgical chylothorax, each one treated with a different approach. The first and second cases were successfully managed with Lipiodol lymphangiography, which allowed for the visualization and occlusion of the injured lymphatic duct, leading to the resolution of the chylothorax. The third case involved thoracic duct embolization, a procedure that resulted in the closure of the duct responsible for the chylous effusion. The last case involved a patient who developed left‐sided chylothorax following a pulmonary resection. The patient experienced chylous leakage early in the postoperative period and underwent a revision thoracoscopy for hemostasis and thoracic duct ligation. During the procedure, indocyanine green (ICG) fluorescence was used to effectively identify and ligate the injured chylous duct. This case series highlights the variety of therapeutic strategies available for the management of chylothorax, emphasizing the importance of a structured, stepwise approach tailored to the specific needs of each patient.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ChylothoraxPostoperative ComplicationsThoracic Surgical ProceduresHumansLymphographyThoracic Duct

Stichwörter der Autor:innen

chylothoraxindocyanine green fluorescencelymphangiographylymphatic embolizationthoracic surgery

Autor:innen und Institutionen

  • Thoracic Surgery Unit, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, Padova, Italy.
  • University Radiology, Department of Medicine, University Hospital of Padova, Padova, Italy.

ORCID-Profile: Alberto Busetto

Zitieren

APA

Busetto, A., Cannone, G., Lione, L., Bonis, A., Verzeletti, V., Battistel, M., Rebusso, A., Nicotra, S., Dell'Amore, A., & Rea, F. (2025). Chylothorax After Thoracic Surgery: How We Manage It. Thoracic Cancer, 16(5). https://doi.org/10.1111/1759-7714.70036

Vancouver

Busetto A, Cannone G, Lione L, Bonis A, Verzeletti V, Battistel M, et al. Chylothorax After Thoracic Surgery: How We Manage It. Thoracic Cancer. 2025;16(5). doi:10.1111/1759-7714.70036

BibTeX
@article{Busetto2025,
  author = {Busetto, Alberto and Cannone, Giorgio and Lione, Luigi and Bonis, Alessandro and Verzeletti, Vincenzo and Battistel, Michele and Rebusso, Alessandro and Nicotra, Samuele and Dell'Amore, Andrea and Rea, Federico},
  title = {Chylothorax After Thoracic Surgery: How We Manage It},
  journal = {Thoracic Cancer},
  year = {2025},
  volume = {16},
  number = {5},
  doi = {10.1111/1759-7714.70036}
}
Kostenlos starten →